CONTEXT BIOPHARMA INC has a total of 21 patent applications. Its first patent ever was published in 2014. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are COLTHURST LTD, CHANGZHOU NO 4 PHARMACEUTICAL FACTORY CO LTD and SHANGHAI HUATUO MEDICAL SCIENCE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Hong Kong | 3 | |
#5 | Canada | 2 | |
#6 | Brazil | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Steroids | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Proniuk Stefan | 16 |
#2 | Brittain Harry G | 8 |
#3 | Stefan Proniuk | 4 |
#4 | Werner Silvia | 4 |
#5 | Zukiwski Alexander | 4 |
#6 | Tilstam Ulf | 4 |
#7 | Rauter Holger | 4 |
#8 | Bindernagel Holger | 4 |
#9 | Silvia Werner | 1 |
#10 | Holger Bindernagel | 1 |
Publication | Filing date | Title |
---|---|---|
US2017182065A1 | Amorphous onapristone compositions and methods of making the same | |
EP3353148A1 | Methods of making onapristone intermediates | |
AU2015243969A1 | Systems and methods for identifying progesterone receptor subtypes |